NCT07237490

Brief Summary

Aim:In this prospective and randomized controlled thesis study; we aimed to compare Modified Constraint-Induced Movement Therapy (mCIMT) delivered via Telerehabilitation with the home program in children with Unilateral Cerebral Palsy (CP) and to determine whether Telerehabilitation has a positive effect on upper extremity functions and quality of life. Method: In our prospective and randomized controlled study, 42 children with unilateral cerebral palsy were included and randomized as the mCIMT group delivered via Telerehabilitation (n=21) and the control group (n=21). The first group received mCIMT treatment together with Telerehabilitation for 1 hour, 3 times a week for 6 weeks. In addition, 30 minutes of indoor activity practices were performed every day. The second group received a home program under the supervision of parents for 1 hour, 3 times a week for 6 weeks. .In the randomized double-blind study, initial assessments, post-treatment and follow-up assessments were performed by the researcher who was blinded to the group distribution. The primary outcome measure was the Assisting Hand Assessment (AHA), which was used to evaluate upper extremity function. The researcher administering this assessment was blinded to group allocation. Secondary outcome measures included the Modified Jebsen Taylor Hand Function Test, range of motion assessed with a goniometer, spasticity evaluated using the Modified Ashworth Scale, grip strength measured with a Jamar dynamometer, manual ability classified using the Manual Ability Classification System (MACS), activities of daily living assessed by ABILHAND-Kids, and quality of life evaluated using the KINDL questionnaire. Post-treatment assessments were performed at the beginning of the study and 6 weeks after treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 12, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2025

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

September 24, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 25, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 19, 2025

Completed
Last Updated

November 19, 2025

Status Verified

July 1, 2025

Enrollment Period

1.7 years

First QC Date

September 24, 2025

Last Update Submit

November 16, 2025

Conditions

Keywords

Cerebral palsy, telerehabilitation , mCIMT, exercise, hand functions

Outcome Measures

Primary Outcomes (1)

  • Assisting Hand Assessment

    The AHA is a test that measures how patients with upper extremity dysfunction, such as hemiplegic CP or congenital brachial plexus injury, use their affected hand in conjunction with their unaffected hand during two-handed play. It was first validated in children aged 18 months to 5 years (Small Kids AHA), and then two play tables were created for children aged 6 to 12 years (School Kids AHA). In this assessment method, a camera records the child performing tasks and playing with both hands. This assessment method can be administered by healthcare professionals who have completed the training and received certification. The test consists of two stages: first, the assessor (therapist, physician) sits opposite the child, and an environment is prepared using age-appropriate toys from the AHA kit to enable the child to perform all upper extremity functions using both hands. A camera positioned behind the assessor records this process.

    before treatment and 6 weeks after treatment

Secondary Outcomes (6)

  • ABILHAND KIDS

    before treatment and 6 weeks after treatment

  • Modified Jebsen-Taylor Hand Function Test

    before treatment and 6 weeks after treatment

  • Joint Range of Motion

    before treatment and 6 weeks after treatment

  • Grip Strength

    before treatment and 6 weeks after treatment

  • Modified Ashworth Scale

    before treatment and 6 weeks after treatment

  • +1 more secondary outcomes

Study Arms (2)

via Telerehabilitation mCIMT

ACTIVE COMPARATOR

The first group received mCIMT treatment together with Telerehabilitation for 1 hour, 3 times a week for 6 weeks. In addition, 30 minutes of indoor activity practices were performed every day. The second group received a home program under the supervision of parents for 1 hour, 3 times a week for 6 weeks.

Other: mCIMT via Telerehabilitation

home exercises control group

ACTIVE COMPARATOR

A 1-hour home program will be implemented 3 days a week.

Other: home exercise program

Interventions

In this group, patients aged 4-12 with unilateral cerebral palsy received mCIMT via the Eczacıbaşı EVITAL app for upper extremity rehabilitation. For six weeks, they performed mCIMT three times a week for one hour under therapist supervision and with parental supervision, two times a week for one hour under parental supervision, and half an hour each day of selected daily activities using the affected extremity, with gloves on the unaffected extremity.

via Telerehabilitation mCIMT

Patients in this group with unilateral CP underwent a home exercise program, which they continued for one hour, three days a week. The upper extremity exercise program included range of motion exercises, stretching exercises, activities of daily living exercises, and play-based exercises. This program lasted an average of 60 minutes.

home exercises control group

Eligibility Criteria

Age4 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Diagnosis of unilateral CP by a specialist
  • Ability to extend the suspected wrist more than 10°
  • Demonstration of ability to follow simple commands and participation in assigned tasks
  • Gross Motor Function Classification System Level 1 or 2
  • Manual Skills Classification System Level 1, 2 or 3
  • Muscle tone is normal/mild/moderate (Modified Ashworth Scale level 0-1-2)
  • No contractures in the upper extremity
  • Agrees to attend intensive therapy sessions and to stop all other upper extremity therapeutic interventions for the 3-month follow-up period

You may not qualify if:

  • Significant contractures in the wrist, elbow, and fingers that prevent daily activities
  • Lack of active movement in the affected upper extremity
  • Cognitive impairment that causes inability to understand and perform simple commands and tasks
  • Inability to continue treatment protocol due to school schedule
  • Uncontrolled disease (endocrinologic, cardiovascular, pulmonary, hematologic, hepatic, renal), active systemic inflammatory disease, and/or history of malignancy
  • Current or previous treatments not compatible with the study treatment protocol
  • Orthopedic surgery (tendon transfer/tendon lengthening) performed on the affected upper extremity
  • Botulinum toxin injection into upper extremity muscles within the last 6 months
  • Dorsal rhizotomy
  • Intrathecal baclofen pump

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University

Istanbul, Fatih, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Cerebral PalsyMotor Activity

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesBehavior

Study Officials

  • Ayşe R AYDIN, Professor Doctor

    Istanbul University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective Randomized Controlled Trial - Single Blinded
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor (Res. Assist. Dr.)

Study Record Dates

First Submitted

September 24, 2025

First Posted

November 19, 2025

Study Start

December 12, 2023

Primary Completion

September 10, 2025

Study Completion

September 25, 2025

Last Updated

November 19, 2025

Record last verified: 2025-07

Locations